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Diuron (3-[3,4-dichlorophenyll-l,l-dimethylurea), an inhibitor of mitochondrial respiration, blocks the 
yeast respiratory chain between cytochrome b and c,. Diuron-resistant mutants of Saccharomyces cerevisiae 
have been selected and several mutations localized to the mitochondrial cytochrome b gene. The present 
paper identifies specific DNA base changes within the cytochrome b gene conferring diuron-resistance. 
DNA sequence analysis was done utilizing primer extension of crude mitochondrial RNA preparations in 
the presence of reverse transcriptase. Five independent diuron-resistant mutations have been sequenced. 
(Saccharomyces cerevisiae) Diuron resistance Mitochondrial cytochrome b split gene 
DNA sequence analysis Primer extension Mutational alteration 
1. INTRODUCTION 
Dim-on (3-[3,4-dichlorophenyl]-l,l-dimethyl- 
urea) is an inhibitor of the yeast respiratory chain 
which blocks the electron flow between cyto- 
chromes b and cl [l]. Several diuron-resistant 
mutants of Saccharomyces cerevisiae have been 
selected on glycerol in the presence of inhibitory 
concentrations of diuron [2]. The mutations were 
found to be of mitochondrial heredity and were 
located at two loci of the apocytochrome b gene. 
The diul locus was found to belong to exon 4 and 
the diu2 locus has been attributed to exon 1 of the 
long cytochrome b gene [3,4]. The cytochrome b 
gene carries other drug-resistant loci (fig. 1). In ad- 
dition to diu2, exon 1 carries three loci anal, mucl 
and myxl; exon 4 carries ana and funl; exon 5 
This paper will be reported in part in the 4th EBEC 
Reports 
carries muc3 and exon 6 carries muc2 and myx2 
(fig.1). The wild type sequence of the yeast cyto- 
chrome b gene is known [8] and a hydropathy plot 
of the deduced amino acid sequence has been used 
to construct a protein folding model [9]. The iden- 
tification of specific DNA sequence changes within 
the cytochrome b gene codons of drug-resistant 
mutants has recently become practical. Thus, iden- 
tified nucleotide changes responsible for resistant 
phenotypes can now be localized precisely within 
their respective exons and to a particular segment 
of the cytochrome b hydropathy plot. We describe, 
here, the determination of the exact DNA base 
changes within the cytochrome b gene of five in- 
dependently isolated diuron-resistant mutants. The 
mutational alterations will be discussed in relation 
to their deduced amino acid change, to their par- 
ticular position in the current protein folding 
model of the cytochrome b protein and to the con- 
served or unconserved nature of the implicated 
amino acid. 
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2. MATERIALS AND METHODS Table 1 
2.1. Strains 
KLlMA, a his1 trp2 OH-1 capl-321 parl-452; 
IL125-2B, his1 ieu; D273-lOB/A21, met olil-625 
ery3-624 parl-626; KL 14-4A/diu2-726; KL 14-4A/ 
diu2-728; KLl4-4A/di~2-76~ IL1252B/diul-721; 
D273- 1 OB/A2 I /diul-724. All diuron-resistant 
mutations but one, diu2-766 (from Colson, un- 
published), have been mapped in [3]. 
Mutational alterations in the cytochrome b gene of 
diuron-resistant mutants 
2.2. Sequence analyses 
The experimental procedure was as described in 
[lo}. Primers of about 20 nucleotides were syn- 
thesized. The choice of the primers (PI-PS) 
depended on the position of the mutations in the 
gene (fig. 1). The location of each primer has to be 
downstream from the mutated sites. Since diuron- 
resistant mutations are mapped at two loci (diul 
and diu2) and belong to the first and the fourth ex- 
on of the cytochrome b split gene, several primers 
were needed. For exon 1, three primers (Pl-P3) 
were used whereas two primers (P4 and PS) were 
utilised for exon 4. 
Mutation Exon Codon Amino acid 
change 
Change Number 
diu2- 766 E 1 AUU UUU Ile Phe 17 
diu2-726 El AAU AAA Asn Lys 31 
diu2- 728 E 1 AAU AAA Asn Lys 31 
diul-72I E4 UUU UCU Phe Ser 225 
diul-724 E4 UUU UCU Phe Ser 225 
The mutations have been mapped in the cytochrome b 
split gene. The position of the diuron-resistant loci and 
the exons limits are given in fig.1. The position of the 
deduced amino acid change is presented in fig.2 
3. RESULTS AND DISCUSSION 
Several mutational alterations have been 
detected (table 1). In exon 1, mutation diu2-766 in- 
duces a transversion from A to T which will change 
codon AUU into UUU resulting in the replacement 
of amino acid no. 17 isoleucine by a phenylalanine. 
In the same exon, two independent mutations 
diu2-726 and diud-728 carry the same transversion 
from T to A which changes codon AAU into AAA 
leading to the replacement of amino acid no.31 
asparagine by lysine. In exon 4, two other indepen- 
dent mutations diul-721 and diul-724 were found 
to carry a transition from T to C altering codon 
UUU into UCU, thus changing amino acid no.225 
from phenylalanine to serine. 
416 15 75 252 54 351 
< , 
El E2 E3 E4 ES E6 
PI P2 P3 
-SGLB---U-B 
PS 
m-4--- 
Two observations favor the fact that the 
detected alterations are indeed those conferring 
diuron-resistance: first, the existence of indepen- 
dent mutants which carry the same nucleotide 
change; second, the absence of polymorphisms 
among the tested strains and the published se- 
quence of the cytochrome b gene. 
DIU2 DlUl 
ANA 1 ANA2 
FUN 1 
MUC I MUC3 WC2 
MYX 1 MYX2 
Fig. 1. Drug-resistant loci of the cytochrome b split gene. 
The exons are numbered from El to E6. The length of 
each exon is given in base pairs. The primers utilized for 
the sequencing experiments are numbered from Pl to 
P5. The position of the primers is given on the basis of 
their first and last bp numbers on the cytochrome b split 
gene. Pl, 189-208; P2, 279-298; P3, 2716-2734; P4, 
4554-4573; P.5, 6118-6140. DIU, diuron-resistance (31; 
ANA, antimycin-resistance [S]; FUN, funiculosin- 
resistance [S]; MUC, mucidin-resistance [3,6]; MYX, 
myxothiazol-resistance [7]. 
The position of each mutated amino acid has 
been indicated on a protein folding model of 
cytochrome b adapted from [9] (fig.2). On this 
basis, all mutations appeared to be located in 
hydrophilic segments of the protein and were 
located on either side of the membrane. The 
32 kDa protein of chloroplast photosystem II is 
known to bind diuron and mutations resulting in 
single amino acid changes within this protein have 
also been shown to confer diuron-resistance Ill]. 
In contrast to the position of the altered amino 
acids of the yeast c~ochrome b diuron-resistant 
mutants, the changed amino acids of the 32 kDa 
protein seem to be located in a lipophilic segment 
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Fig.2. Altered amino acids in the cytochrome b 
polypeptide of diuron-resistant mutants. Mutation 
diu2-766 was found to alter amino acid no.17. 
Mutations diu2-726 and diu2-728 were found to affect 
the amino acid no.31. Mutations diul-721 and diul-724 
were found to alter amino acid no.225. The exons are 
numbered El-E6. The exon limits are indicated by 
of the protein. It should be pointed out however, 
that two of the three altered nucleotides in the 
32 kDa protein were found to be located closer to 
either one or other side of the membrane. This 
situation is similar to that found with diuron- 
resistant mutations in yeast cytochrome 6. These 
observations might suggest hat diuron could act at 
two specific sites at either side of the membrane. 
Diuron-resistance results when amino acids with 
more hydrophilic side chains are exchanged for the 
amino acids at positions 31 and 225, polar to 
positively charged and non-polar to polar, respec- 
tively. Steric effects may lead to diuron-resistance 
at positions 17 and 225 since resulting mutations 
change an aromatic phenylalanine into a non- 
aromatic amino acid serine residue (position 225) 
and an isoleucine into phenylalanine (position 17). 
The mutated amino acid asparagine no.31 is 
conserved in cytochrome b isolated from a variety 
of species but is not conserved in chloroplast 
cytochrome b6 which is known to be insensitive to 
diuron. The 17 kDa (subunit 4) protein of the 
chloroplast b,$ complex is homologous to the 
second half of the mitochondrial cytochrome b 
polypeptide [9]. The mutated amino acid 
phenylalanine no.225 is found at the appropriate 
position within the 17 kDa protein and is also con- 
served in cytochrome b isolated from Aspergilhs 
nidulans. This amino acid is not conserved in 
mammalian (bovine, human, mouse) cytochrome 
b but it is replaced by an aromatic tyrosine residue 
in these species. The amino acid isoleucine no.17 is 
conserved in A. nidulans and in the cytochrome 66 
of the spinach chloroplast. Surprisingly, it is 
already changed into a phenylalanine in mam- 
malian cytochrome b which apparently are 
naturally resistant o diuron. Finally, in yeast this 
mutated amino acid of exon 1 is in the third posi- 
tion of a short amino acid sequence Ser-Tyr-Ile_Ile. 
This sequence also surrounds the mutated amino 
acid no.225 in exon 4: Ser-Tyr-&-Be. This se- 
quence is found at two positions in yeast (17 and 
225) and around amino acid no.17 in both yeast 
and A. nidulans. 
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